HUMAN ALBUMIN GRIFOLS 20% I.V. INJECTION 20 Solution 50ml Vial

Product Overview

Human Albumin Grifols 20% I.V. Injection 50ml Vial is a sterile, pyrogen-free solution of human albumin, a protein derived from human plasma.

It is clinically used for plasma volume expansion and maintaining oncotic pressure in various medical conditions where there is a deficiency of circulating albumin.

Grifols, a global healthcare company with a rich history in plasma-derived medicines, ensures the highest safety standards through rigorous donor screening and viral inactivation processes.

Key Benefits

• Effective plasma volume expansion: Rapidly restores circulating blood volume in patients with hypovolemia or shock.
• Maintains oncotic pressure: Essential for fluid balance between blood vessels and tissues, preventing edema.
• Transports vital substances: Albumin acts as a carrier for hormones, enzymes, drugs, and toxins in the bloodstream.
• Viral safety: Manufactured with advanced viral inactivation and removal procedures to ensure product safety.
• Versatile therapeutic use: Indicated for a wide range of conditions including burns, acute liver failure, and hypoalbuminemia.

How to Use

1. Human Albumin Grifols 20% I.V. Injection must be administered intravenously by a qualified healthcare professional.
2. The dosage and infusion rate should be individualized based on the patient's clinical condition, diagnosis, and response to treatment.
3. Before administration, visually inspect the solution for particulate matter and discoloration; the solution should be clear and amber.
4. Do not dilute with water for injection as this may cause hemolysis in recipients.
5. Once the vial has been opened, the contents should be used immediately.

Caution & Warnings

• Hypersensitivity reactions: Monitor patients for signs of allergic reactions, including hives, rash, itching, or anaphylaxis. Discontinue use immediately if such reactions occur.
• Circulatory overload: Administer with caution in patients at risk of circulatory overload (e.g., heart failure, severe renal impairment) due to the risk of pulmonary edema.
• Electrolyte imbalance: Monitor serum electrolytes, particularly sodium levels, as rapid infusion can lead to dilutional hyponatremia.
• Coagulation abnormalities: High doses or rapid infusion may cause changes in coagulation parameters.
• Specific patient populations: Use with caution in patients with severe anemia or cardiac failure.
• Do not use if the solution is cloudy or contains particulate matter, or if the vial is damaged.

Ingredients

Each 100ml of Human Albumin Grifols 20% contains 20g of human albumin.

Excipients typically include sodium chloride, sodium caprylate, sodium N-acetyltryptophanate, and water for injections.

Product Details

Form: Solution for Intravenous Infusion

Strength: 20% (20g/100ml)

Volume: 50ml

Container Type: Glass Vial

Manufacturer: Grifols

Drug Type: Prescription Only Medicine